China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

Shares of NYSE CPHI opened at $0.20 on Friday. China Pharma has a 52-week low of $0.17 and a 52-week high of $0.74. The business’s 50 day moving average is $0.23 and its two-hundred day moving average is $0.24. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.